In breast cancer cell line MCF-7, Kumari et al. [52] demonstrated that artemisin inhibits HDAC1, HDAC2 and HDAC6 activity, and displays nonepigenetic effects, including inhibition of cell proliferation, migration and invasion, and apoptosis enhancement [52]. Here, HDAC1 is linked to breast carcinoma.